Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for Atherosclerosis.

J Atheroscler Thromb · 2026 · PMC12782876 · PMID 40850750

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

did not reach statistical significancep = 0.098so close (0.05 < p ≤ 0.1)

Although the reduction in TG levels did not reach statistical significance ( p = 0.098), the observed trend indicates a clinically meaningful improvement, particularly in the diabetic subgroup.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.